(Q37559385)

21 August 2017

Comparison of oral and intravenous alfacalcidol in chronic hemodialysis patients (English)

1 reference

21 August 2017

Michel Vallée

8

0 references

author name string

Myriam Lessard

1

1 reference

21 August 2017

Denis Ouimet

2

1 reference

21 August 2017

Martine Leblanc

3

1 reference

21 August 2017

Annie-Claire Nadeau-Fredette

4

1 reference

21 August 2017

Robert Bell

5

1 reference

21 August 2017

Jean-Philippe Lafrance

6

1 reference

21 August 2017

Vincent Pichette

7

1 reference

21 August 2017

4 February 2014

1 reference

21 August 2017

1 reference

21 August 2017

15

1 reference

21 August 2017

27

1 reference

Tinzaparin reduces health care resource use for anticoagulation in hemodialysis

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Intravenous calcitriol therapy in an early stage prevents parathyroid gland growth

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

A review of intravenous versus oral vitamin D hormone therapy in hemodialysis patients.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Intravenous versus oral vitamin d therapy in dialysis patients: what is the question?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Use of oral and parenteral calcitriol in the treatment of renal osteodystrophy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

The importance of bone biomarkers in the diagnosis of renal osteodystrophy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Oral versus intravenous calcitriol: is the route of administration really important?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Calcitriol administration in end-stage renal disease: intravenous or oral?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

New clinical trials with vitamin D and analogs in renal disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Comparison of intermittent intravenous and oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients: a meta-analysis of randomized controlled trials.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Intravenous alfacalcidol once weekly suppresses parathyroid hormone in hemodialysis patients

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Comparative efficacy of oral and intravenous calcitriol treatment in haemodialysis patients: effects on serum biochemistry and cytokine levels

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915223

Intermittent oral versus intravenous alfacalcidol in dialysis patients

1 September 2018

1 reference

12 December 2020

Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD

1 reference

12 December 2020

Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density

1 reference

12 December 2020

Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients

1 reference

12 December 2020

Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients

1 reference

12 December 2020

'Pulse oral' versus intravenous calcitriol therapy in chronic hemodialysis patients. A prospective and randomized study

1 reference

12 December 2020

Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite

1 reference

12 December 2020

Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients

1 reference

12 December 2020

Meta-analysis: vitamin D compounds in chronic kidney disease

1 reference

12 December 2020

Intravenous alfacalcidol once weekly pulse therapy for secondary hyperparathyroidism in hemodialysis patients

1 reference

12 December 2020

The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism

1 reference

12 December 2020

A randomized trial of intermittent versus continuous oral alfacalcidol treatment of hyperparathyroidism in end-stage renal disease

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2369-15-27

1 reference

21 August 2017

1 reference

21 August 2017

1 reference